Related Experiment Videos
Valproic acid and thrombocytopenia: cross-sectional study
1Developmental Disabilities Unit, Department of Paediatrics, Caritas Medical Centre, 111 Wing Hong Street, Shamshuipo, Hong Kong.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|June 15, 2001
Summary
High valproic acid levels and older age increase the risk of thrombocytopenia in children. Monitoring platelet counts is crucial for patients on high-dose valproic acid therapy, especially those with other risk factors.
Area of Science:
- Pediatric Neurology
- Clinical Pharmacology
- Hematology
Background:
- Valproic acid is a widely used antiepileptic drug in children.
- Thrombocytopenia is a known potential side effect of valproic acid therapy.
- Understanding risk factors for valproic acid-induced thrombocytopenia is crucial for patient safety.
Purpose of the Study:
- To examine the relationship between serum valproic acid levels and platelet count in neurologically impaired children.
- To identify factors, including age, duration of therapy, and polytherapy, associated with thrombocytopenia.
- To assess the clinical significance of thrombocytopenia in children receiving high-dose valproic acid.
Main Methods:
- A cross-sectional study was conducted involving 96 neurologically impaired children on valproic acid and 48 controls.
- Platelet counts, serum valproic acid levels, dosage, age, and duration of therapy were analyzed.
- Valproic acid dosage threshold was set at 40 mg/kg/day.
Main Results:
- Thrombocytopenia occurred in 17.7% of the valproic acid group versus 4.2% in controls (P<0.05).
- Platelet count showed negative correlation with serum valproic acid level and age, and positive correlation with polytherapy.
- Higher trough serum valproic acid levels (>450 micromol/L) or daily doses (>40 mg/kg) were linked to increased thrombocytopenia risk.
Conclusions:
- Clinicians should be aware of the risk of thrombocytopenia with trough valproic acid levels >450 micromol/L or daily doses >40 mg/kg.
- The risk of valproic acid-induced thrombocytopenia is elevated in older children.
- Regular platelet count monitoring is recommended for children on high-dose valproic acid, particularly those on concomitant medications or undergoing surgery.